sTMS for Substance Use-disordered Veterans

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if synchronized transcranial magnetic stimulation is safe and tolerable in individuals with cocaine, opioid, or alcohol use disorders.

Clinical Trial Description

All non-life-saving human research studies suspended by sponsor in response to COVID19 social distancing policies The goal of this proposal is to evaluate preliminary participant response to a pilot, controlled, feasibility study to evaluate changes in craving, substance use, and quality of life after 6 weeks of a low-risk non-invasive brain stimulation technique, called Synchronized Transcranial Magnetic Stimulation (sTMS), compared to sham, in Veterans with a substance use disorder (SUD). An important focus of this application will be evaluating the acceptability, tolerability, and safety of sTMS in this population. To the investigators knowledge, sTMS has never been used for SUDs, and holds considerable promise as a future treatment option for these prevalent disorders. However initial work in the acceptability, tolerability, and safety of this approach must be conducted first. This project is the first step towards the investigators long-term goal, which is to combine non-invasive brain stimulation with individualized psychotherapy or pharmacotherapy to reduce SUD problems and improve quality of life for Veterans. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04336293
Study type	Interventional
Source	VA Office of Research and Development
Contact
Status	Completed
Phase	N/A
Start date	September 7, 2021
Completion date	December 29, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02939352` - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues	Early Phase 1
Completed	`NCT01822587` - Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving	Phase 2
Completed	`NCT01601743` - Exercise as a Behavioral Treatment for Cocaine Dependence	N/A
Completed	`NCT02563769` - Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study	Phase 1
Completed	`NCT01651377` - Pramipexole as a Treatment for Cocaine Dependence	Phase 1
Completed	`NCT02768441` - Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots	Early Phase 1
Completed	`NCT02626494` - Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction	Phase 4
Recruiting	`NCT02892851` - Deep Brain Stimulation of the Sub-Thalamic Nucleus to Treat Severe and Treatment-resistant Cocaine Addiction.	N/A
Not yet recruiting	`NCT01319214` - Reducing Drug Craving Memories	N/A
Recruiting	`NCT01259362` - Effects of Repeated Transcranial Magnetic Stimulation (rTMS) on the Treatment of Cocaine Addicted Patients	Phase 2
Completed	`NCT01211418` - Integrative Meditation (IM) for Cocaine Addiction	N/A
Recruiting	`NCT03423667` - Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction	Phase 2
Completed	`NCT01984177` - Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence	N/A
Completed	`NCT01887366` - Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects	Phase 2
Completed	`NCT01337297` - Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction	Phase 1/Phase 2
Completed	`NCT01067846` - Cognitive Enhancement and Relapse Prevention in Cocaine Addiction	N/A
Completed	`NCT01651364` - A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence	Phase 1
Recruiting	`NCT03018236` - Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.	Phase 4
Completed	`NCT01929343` - Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving	Phase 2
Completed	`NCT01281202` - Vigabatrin for the Treatment of Cocaine Dependency	Phase 2/Phase 3